| Rosetta D Hixson, MD | |
|
2800 10th Ave N, Billings, MT 59101 | |
| (406) 238-2500 | |
| Not Available |
| Full Name | Rosetta D Hixson |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 2800 10th Ave N, Billings, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104137496 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD.206370 (Louisiana) | Secondary |
| 208M00000X | Hospitalist | 206370 (Louisiana) | Secondary |
| 208M00000X | Hospitalist | MED-PHYS-LIC-65836 (Montana) | Primary |
| Entity Name | Administrators Of The Tulane Educational Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528014164 PECOS PAC ID: 0446163760 Enrollment ID: O20031201000636 |
News Archive
Today, PWSA (USA) announced its support for H.R.4144 - Ending the Diagnostic Odyssey Act of 2019, a bill to enable States to better provide access to whole genome sequencing clinical services for certain undiagnosed children under the Medicaid program, and for other purposes.
Results of the first ever trial to show that a safe and effective dengue vaccine may be possible are published Online First in The Lancet.
Elusys Therapeutics, Inc., a biopharmaceutical company developing biodefense countermeasures, announced today that it has been awarded the first U.S. Government contract to develop an anti-toxin for pre- and post-exposure prophylaxis (PEP) use via intramuscular injection.
IBM and the University of Texas Medical Branch (UTMB) launched an effort using IBM's World Community Grid "virtual supercomputer" to allow laboratory tests on drug candidates for drug-resistant influenza strains and new strains, such as H1N1, in less than a month.
› Verified 4 days ago
| Entity Name | Lc Hospital Medicine Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417654724 PECOS PAC ID: 9739546805 Enrollment ID: O20230605001940 |
News Archive
Today, PWSA (USA) announced its support for H.R.4144 - Ending the Diagnostic Odyssey Act of 2019, a bill to enable States to better provide access to whole genome sequencing clinical services for certain undiagnosed children under the Medicaid program, and for other purposes.
Results of the first ever trial to show that a safe and effective dengue vaccine may be possible are published Online First in The Lancet.
Elusys Therapeutics, Inc., a biopharmaceutical company developing biodefense countermeasures, announced today that it has been awarded the first U.S. Government contract to develop an anti-toxin for pre- and post-exposure prophylaxis (PEP) use via intramuscular injection.
IBM and the University of Texas Medical Branch (UTMB) launched an effort using IBM's World Community Grid "virtual supercomputer" to allow laboratory tests on drug candidates for drug-resistant influenza strains and new strains, such as H1N1, in less than a month.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rosetta D Hixson, MD Po Box 35100, Billings, MT 59107-5100 Ph: (406) 238-2500 | Rosetta D Hixson, MD 2800 10th Ave N, Billings, MT 59101 Ph: (406) 238-2500 |
News Archive
Today, PWSA (USA) announced its support for H.R.4144 - Ending the Diagnostic Odyssey Act of 2019, a bill to enable States to better provide access to whole genome sequencing clinical services for certain undiagnosed children under the Medicaid program, and for other purposes.
Results of the first ever trial to show that a safe and effective dengue vaccine may be possible are published Online First in The Lancet.
Elusys Therapeutics, Inc., a biopharmaceutical company developing biodefense countermeasures, announced today that it has been awarded the first U.S. Government contract to develop an anti-toxin for pre- and post-exposure prophylaxis (PEP) use via intramuscular injection.
IBM and the University of Texas Medical Branch (UTMB) launched an effort using IBM's World Community Grid "virtual supercomputer" to allow laboratory tests on drug candidates for drug-resistant influenza strains and new strains, such as H1N1, in less than a month.
› Verified 4 days ago
Andrea L. Darilek, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-657-4000 | |
James Austin Jackson, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Matthew Francis Hartman, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Shelly Lynn Basye, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Marilyn F. Grams, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2825 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Alyssa Victoria Burkhart, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Laura A Szabo, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 |